B. Lank

12 papers receiving 312 citations

Peers

B. Lank
Comparison fields: 5 of 63
  • Molecular Medicine 92
  • Clinical Biochemistry 105
  • Oncology 241
  • Applied Microbiology and Biotechnology 16
  • Emergency Medicine 55
Replace Zinner Sh with:
Zinner Sh
Davis M. Hahn United States
Schimpff Sc
Carlos A. De Jongh United States
Marie J. Gribble Canada
T. Schmeiser Germany
Mickaël Aoun Belgium
Sanjay Biswas India
M. F. Kergueris France
A.P. Gillett United Kingdom
B. Lank relative to Zinner Sh Zinner Sh's profile →
Citations per field
00.5×1.5×
Zinner Sh · 1×
Citations per year

Countries citing papers authored by B. Lank

Since Specialization
Citations

This map shows the geographic impact of B. Lank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Lank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Lank more than expected).

Fields of papers citing papers by B. Lank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Lank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Lank. The network helps show where B. Lank may publish in the future.

Co-authors

The 19 scholars most cited alongside B. Lank, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Lank Line = papers co-authored together B. Lank links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 1979187
2 197873
3 197642
4 197830
5 198126
6 198321
7
Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections.
197911
8 197610
9 19788
10
Herpes simplex encephalitis: poor outcome despite adenine arabinoside therapy.
19824
11
A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
19754
12 19782
13
Clinical and laboratory study of tobramycin in the treatment of infections due to gram-negative organisms.
19771

About B. Lank

B. Lank is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Oncology and Epidemiology, having authored 13 papers that have together received 419 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Neutropenia and Cancer Infections (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Hematological disorders and diagnostics (2 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Essential Oils and Antimicrobial Activity (2 papers). The work is most often cited by research in Molecular Medicine (92 citations), Clinical Biochemistry (105 citations), Oncology (241 citations), Applied Microbiology and Biotechnology (16 citations) and Emergency Medicine (55 citations). B. Lank has collaborated with scholars based in Canada and United States. Frequent co-authors include Allan Ronald, G. K. M. Harding, Marc Gurwith, James Brunton, C. F. T. Snelling, Jutta K. Preiksaitis, Larry W. Brox, Phillip Ng, D L Tyrrell and G. A. LePage. Their work appears in journals such as The American Journal of Medicine, The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy, Cancer and Journal of Antimicrobial Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact